( OTC-PINK:OHRP,OTC-QB:OHRP )

News from Ohr Pharmaceutical Inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Aug 09, 2013, 09:10 ET Ohr Pharmaceutical to Present at the Wedbush Life Sciences Management Access Conference on August 14th

 Ohr Pharmaceutical (NasdaqCM: OHRP), a pharmaceutical company focused on the development of novel therapeutics for large unmet medical needs,...


Aug 07, 2013, 09:00 ET Ohr Pharmaceutical Announces Addition of Dr. John Wroblewski to Ophthalmic Scientific Advisory Board

Ohr Pharmaceutical Inc. (NasdaqCM: OHRP) today announced the addition of John J. Wroblewski M.D. to its Scientific Advisory Board ("SAB"). The...


May 22, 2013, 08:30 ET Ohr Pharmaceutical Appoints June S. Almenoff to Board of Directors

 Ohr Pharmaceutical Inc. (OTCQB: OHRP), a pharmaceutical company focused on the development of novel therapeutics for unmet medical needs,...


May 02, 2013, 07:00 ET Ohr Pharmaceutical Appoints Thomas M. Riedhammer To Board Of Directors

 Ohr Pharmaceutical Inc. (OTCQB: OHRP), a pharmaceutical company focused on the development of novel therapeutics for unmet medical needs,...


Apr 22, 2013, 07:00 ET Ohr Pharmaceutical Announces $5 Million Financing from Exercise of Warrants

 Ohr Pharmaceutical Inc. (OTCQB: OHRP), a pharmaceutical company focused on the development of novel therapeutics for unmet medical needs,...


Feb 07, 2013, 09:15 ET Ohr Pharmaceutical to Present at 15th Annual BIO CEO & Investor Conference

 Ohr Pharmaceutical Inc. (OTCQB: OHRP), a pharmaceutical company focused on the development of novel therapeutics for large unmet medical...


Jan 03, 2013, 09:15 ET Ohr Pharmaceutical To Present At Biotech Showcase 2013 in San Francisco

  Ohr Pharmaceutical (OTCQB: OHRP), a pharmaceutical company focused on the development of novel therapeutics for large unmet medical needs,...


Dec 27, 2012, 09:15 ET Ohr Pharmaceutical Provides Update to Shareholders on 2012 Accomplishments and Milestones for 2013

 Ohr Pharmaceutical Inc., a pharmaceutical company dedicated to the clinical development of new drugs for underserved therapeutic needs in...


Nov 20, 2012, 08:15 ET Ohr Pharmaceutical Announces Additions to Ophthalmic Scientific Advisory Board

 Ohr Pharmaceutical Inc. (OTCBB: OHRP) today announced the addition of two prominent ophthalmologists to its Scientific Advisory Board ("SAB")...


Oct 05, 2012, 09:20 ET Ohr Pharmaceutical to Present at the 11th Annual BIO Investor Forum

 Ohr Pharmaceutical (OTCBB: OHRP), a pharmaceutical company focused on the development of novel therapeutics for large unmet medical needs,...